4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0001638599-21-000606
Director bought 1,425,000 shares at $15.00 ($21,375,000)
From the SEC's structured data for this filing
Trades in this filing
BAKER BROS. ADVISORS LP · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-20 | Purchase : show line 1 in the form | +104,698 | $15.00 | $1,570,470 | 104,698 | I |
| 2021-07-20 | Purchase : show line 2 in the form | +1,320,302 | $15.00 | $19,804,530 | 1,320,302 | I |
| Open-market purchases · 1,425,000 sh · avg $15.00 · $21,375,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-20 | Conversion : show line 3 in the form Series C Convertible Preferred Stock | −315,777 | 0 | I |
| 2021-07-20 | Conversion : show line 4 in the form Non-Voting Common Stock | +315,777 | 315,777 | I |
| 2021-07-20 | Conversion : show line 5 in the form Series C Convertible Preferred Stock | −3,960,811 | 0 | I |
| 2021-07-20 | Conversion : show line 6 in the form Non-Voting Common Stock | +3,960,811 | 3,960,811 | I |
Loading xslF345X03/doc4_7293.xml…